Hepatic focal nodular hyperplasia in children previously treated for a solid tumor: Incidence, risk factors, and outcome

Cancer

Volumn 97, Issue 12, 2003, Pages 3107-3113

  Icher De Bouyn, Celine ^a   Leclere, Jerome ^a   Raimondo, Graziella ^a   Le Pointe, Hubert Ducou ^b   Couanet, Dominique ^a   Valteau Couanet, Dominique ^a   Hartmann, Olivier ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Busulfan alkylating agents; Cancer; Children; Focal nodular hyperplasia; Venoocclusive disease

Indexed keywords

ALKYLATING AGENT; BUSULFAN; MELPHALAN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIVER HYPERPLASIA; LIVER ISCHEMIA; LIVER NODULE; MALE; PRIORITY JOURNAL; RADIOTHERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SOLID TUMOR; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VEIN OCCLUSION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; MALE; NEOPLASMS; NEUROBLASTOMA; OVARIAN NEOPLASMS; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0038390554     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11452     Document Type: Article

References (48)

1. Kumagai H, Masuda T, Oikama H, Endo K, Endo M, Takano T. Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol. 2000;15: 1344-1347.
2. Stocker JT, Ishak KG. Focal nodular hyperplasia of the liver: a study of 21 pediatric cases. Cancer. 1981;48:336-345.
3. Cherqui D, Rahmouni A, Charlotte F, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology. 1995;22: 1674-1681.
4. Pain JA, Gimson AES, Williams R, Howard ER. Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut. 1991;32:524-527.
5. Kerlin P, Davis L, McGill DB, Weiland LH, Adson MA, Sheedy PF II. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastoenterology. 1983;84:994-1002.
6. Mc Donald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116-122.
7. Mowat AP. Liver disorders in childhood. London: Butterworth, 1987:324-336.
8. Tomlinson GE, Finegold MJ. Tumors of the liver. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott, 2002;847-864.
9. Reymond D, Plaschkes J, Ridolfi Lüthy A, Leibundgut K, Hirt A, Wagner HP. Focal nodular hyperplasia of the liver in children: review of follow-up and outcome. J Pediatr Surg. 1995;30:1590-1593.
10. Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver. A comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441-1454.
11. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am. 1975;59:995-1013.
12. Knowles DM II, Wolff M. Focal nodular hyperplasia of the liver. A clinicopathologic study and review of the literature. Hum Pathol. 1976;7:533-545.
13. Carlson SK, Johnson CD, Bender CE, Welch TJ. CT of focal nodular hyperplasia of the liver. AJR Am J Roentgenol. 2000; 174:705-712.
14. Cheon JE, Kim WS, Kim IO, Jang JJ, Seo JK, Yeon KM. Radiological features of focal nodular hyperplasia of the liver in children. Pediatr Radiol. 1998;28:878-883.
15. Weimann A, Ringe B, Klempnauer J, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg. 1997;21:983-991.
16. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983-993.
17. Learch TJ, Ralls PW, Johnson MB, et al. Hepatic focal nodular hyperplasia: findings with color Doppler sonography. J Ultrasound Med. 1993;12:541-544.
18. Shirkhoda A, Farah MC, Bernacki E, Madrazo B, Roberts J. Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging. 1994;19:34-38.
19. Vilgrain V, Fléjou JF, Arrivé L, et al. Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology. 1992;184:699-703.
20. Lee MJ, Saini S, Hamm B, et al. Focal nodular hyperplasia of the liver: MR findings in 35 proved cases. AJR Am J Roentgenol. 1991;156:317-320.
21. Dill-Macky M, Frazer C, de Boer WB. Magnetic resonance features of focal nodular hyperplasia of the liver. Australas Radiol. 1999;43:315-320.
22. Di Stasi M, Caturelli E, De Sio I, Salmi A, Buscarini E, Buscarini L. Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin Ultrasound. 1996;24: 345-350.
23. Golli M, Mathieu D, Anglade MC, Cherqui D, Vasile N, Rahmouni A. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology. 1993;187:113-117.
24. Mortelé KJ, Praet M, Vlierberghe HV, Kunnen M, Ros PR. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol. 2000;175:687-692.
25. Shamsi K, DE Schepper A, Degryse H, Deckers F. Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging. 1993;18:32-38.
26. Buetow PC, Pantongrag-Brown L, Buck JL, Ros PR, Goodman ZD. From the archives of the AFIP. Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radiographics. 1996;16:369-388.
27. Hamrick-Turner JE, Shipkey FH, Cranston PE. Fibrolamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia. J Comput Assist Tomogr. 1994;18:301-304.
28. Saul SH, Titelbaum DS, Gansler TS, et al. The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia. Cancer. 1987;60:3049-3055.
29. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology. 1993;186:133-138.
30. De Carlis L, Pirotta V, Rondinara GF, et al. Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg. 1997;3:160-165.
31. Herman P, Pugliese V, Machado MAC, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg. 2000;24:372-376.
32. Trenschel GM, Schubert A, Dries V, Benz-Bohm G. Nodular regenerative hyperplasia of the liver: case report of a 13- year-old girl and review of the literature. Pediatr Radiol. 2000;30:64-68.
33. Naber AHJ, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol. 1991;12:94-99.
34. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol. 1981;12:60-71.
35. Buffet C, Altman C. Hyperplasie nodulaire régénérative. Gastroenterol Clin Biol. 1994;18:123-132.
36. Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol. 1987;148: 717-722.
37. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787-797.
38. Sadowski DC, Lee SS, Wanless IR, Kelly JK, Heathcote EJ. Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology. 1995;21: 970-975.
39. Wanless IR, Albrecht S, Bilbao J, et al. Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol. 1989;2:456-462.
40. Mathieu D, Kobeiter H, Maison P, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000;118:560-564.
41. Méresse V, Hartmann O, Vassal G, et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfancontaining regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant. 1992;10:135-141.
42. De Sousa JMM, Portmann B, Williams R. Nodular regenerative hyperplasia of the liver and the Budd-Chiari syndrome. Case report, review of the literature and reappraisal of pathogenesis. J Hepatol. 1991;12:28-35.
43. Zafrani ES, Pinaudeau Y, Dhumeaux D. Drug-induced vascular lesions of the liver. Arch Intern Med. 1983;143:495-502.
44. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after irradiation. Arch Pathol Lab Med. 1980;104: 584-588.
45. Kondo F, Nagao T, Sato T, et al. Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension. Pathol Res Pract. 1998; 194:487-495.
46. Kondo F. Focal nodular hyperplasia of the liver: controversy over etiology. J Gastroenterol Hepatol. 2000;15:1229-1231.
47. Brisse H, Servois V, Bouche B, et al. Hepatic regenerating nodules: a mimic of recurrent cancer in children. Pediatr Radiol. 2000;30:386-393.
48. Becker YT, Raiford DS, Webb L, Wright JK, Chapman WC, Wright Pinson C. Rupture and hemorrhage of hepatic focal nodular hyperplasia. Am Surg. 1995;61:210-214.